Nuvo Pharmaceuticals Inc NRIFF

RE: Palidin reports record earnings

[3dollar]

" Pennsaid was mentioned repeatedly in their financial news release today!"

It was mentioned twice both times in a very generic manner.  I'd be surprised if Pennsaid had a significant impact to their bottom line results.  Let's try and keep it real on this board if at all possible.  There's momentum for the 1st time in a long time and we are less than 6 months from a definitive outcome.  Personally I'm hoping they are doing everything they can to sell this thing as it seems to be the most logical option.  no way this management team can be responsible for trying to make Pennsaid a household name in the US.

If the technology is as "wonderful" as the Fqubed and Nuvo claim there is no reason why a significant player out there wouldn't want it and be willoing to pay a price of somewhere between $2-$3/share.  if we don't sell out then are hopes will be on our partner to hit quarterly revenue targets and show the growth potential of this product.  This means we are at the mercy of the "expectation" game which can either derail a stock price and or launch it to unexpected highs.

Owned this thing for almost 15 years now and am currently very cautiously optimistic about our chances to see $1+ share price between now and the FDA "final approval" announcement.